Work

National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid Leukemia

Year: 2025

Type: article

Study design: Observational Study

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2025.4365

Authors: Daniel J. Zheng, Gary Hettinger, Jonathan D. Bender, Alexis C. Boulter, Lusha Cao, Caitlin W. Elgarten, Brian T. Fisher, Cody Gathers, Yuan-Shung V. Huang, Jennifer Ko, Kasey J. Leger, Yimei Li, Regina Myers, Hari K. Narayan, Jose Ortiz, Alix E. Seif, Eleana Vasileiadi, Richard Aplenc, Kelly D. Getz

Institutions: Children's Hospital of Philadelphia, New York University, Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of Cincinnati Medical Center, University of Pennsylvania, Seattle Children's Hospital, University of California San Diego

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G1015374103, G3973428212, G830265429, Treatment-Related Cardiotoxicity in Children with Relapsed Acute Myeloid Leukemia - Natural History, Occurrence and Implications, Physician Scientist Training in Clinical Oncology, CHOP Institutional Training in Pediatric Research

OpenAlex ID: W4415478439

FWCI: 0.629

Cites: 5

Cited by: 1

Related to: